Christopher E. Wolter, MD, presented “Counterpoint: Robotic Uterosacral Ligament Suspension” during the 31st Annual Perspectives in Urology: Point-Counterpoint, on October 18, 2024, in Scottsdale, Arizona.
How to cite: Wolter, Christopher E. “Counterpoint: Robotic Uterosacral Ligament Suspension.” October 18, 2024. Accessed Feb 2025. https://grandroundsinurology.com/counterpoint-robotic-uterosacral-ligament-suspension/
Counterpoint: Robotic Uterosacral Ligament Suspension – Summary
Christopher E. Wolter, MD, debates the merits of robotic uterosacral ligament suspension versus robotic sacrocolpopexy for pelvic organ prolapse repair. In this 11-minute presentation, he acknowledges the efficacy and durability of robotic sacrocolpopexy, while highlighting the emerging role of robotic uterosacral ligament suspension as a viable alternative.
Wolter explains the technical aspects of robotic uterosacral ligament suspension, emphasizing its comparable success rates, reduced operative times, and decreased risk of mesh-related complications. He outlines the surgical advantages of robotic techniques, including superior visualization and the ability to perform precise, high-apex suturing, which reduces ureteral injury risk.
Through comparative analyses, he illustrates that robotic uterosacral ligament suspension demonstrates equivalent quality-of-life improvements and subjective outcomes while offering better preservation of urinary function and lower urgency symptoms than sacrocolpopexy. He concludes that uterosacral ligament suspension is a safer option for high-risk patients and a valuable addition to the surgical repertoire for individualized care.
About the 31st Annual Perspectives in Urology: Point Counterpoint conference: Presented by Program Chair and Grand Rounds in Urology Editor-in-Chief E. David Crawford, MD, this conference brought together leading experts in urology, medical oncology, and radiation oncology to discuss and debate the latest topics in genitourinary cancers, primarily prostate cancer and bladder cancer. This interactive conference offered topical lectures, pro/con debates, interesting-case presentations, interactive panel discussions, and interactive audience and faculty networking.
ABOUT THE AUTHOR
Christopher E. Wolter, MD, is an assistant professor in urology at the Mayo Clinic in Phoenix, Arizona. He has been in practice since 2008, specializing in the areas of urinary incontinence, pelvic organ prolapse, urologic reconstruction, urologic prosthetics, post prostate cancer survivorship, erectile dysfunction, neurourology and neuromodulation, and overall functional considerations of urogenital health. Heavily involved in urologic education, Dr. Wolter has spent the last 12 years involved in resident education and leadership for his department; over the last eight years serving as urology residency program director. He is also the director of urologic education for the preclinical and clinical rotations for the Mayo Clinic Alix School of Medicine in Phoenix.
Dr. Wolter completed his undergraduate and medical education at the University of Illinois. He then completed his urology residency at Tulane University in New Orleans and at Vanderbilt University in Nashville, where he also completed a fellowship in female pelvic medicine and reconstructive urology. In his free time, Dr. Wolter enjoys spending time with his wife and two boys, and their Australian Shepherd, Ella. He enjoys mountain biking, cooking and trying new restaurants, pickleball, and struggles at golf (although he enjoys it).
